|
|
|
Volumn 9, Issue 1, 2004, Pages 16-
|
|
NIAID begins enrolling volunteers for Phase IIB study of Merck's vaccine.
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
HUMAN IMMUNODEFICIENCY VIRUS VACCINE;
ADENOVIRUS;
ARTICLE;
CLINICAL TRIAL;
DRUG INDUSTRY;
GENETICS;
HEALTH CARE ORGANIZATION;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
IMMUNOLOGY;
PHASE 2 CLINICAL TRIAL;
UNITED STATES;
VIROLOGY;
VIRUS GENE;
VIRUS LOAD;
ADENOVIRIDAE;
AIDS VACCINES;
DRUG INDUSTRY;
GENES, VIRAL;
HIV;
HIV INFECTIONS;
HUMANS;
NATIONAL INSTITUTES OF HEALTH (U.S.);
UNITED STATES;
VIRAL LOAD;
|
|
EID: 84921706440
PISSN: 18166253
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (2)
|
|
References (0)
|